Prism Medico and Pharmacy Ltd
Prism Medico and Pharmacy Ltd (PRISMMEDI) last reported results for the quarter ended Dec 2019, with sales of ₹9.75 crore and net profit of ₹-0.04 crore. The stock last traded at ₹30.5, a market capitalisation of ₹41.4 crore. Over the past 52 weeks the stock has ranged between ₹15.5 and ₹34.5. Figures are as of 9 Oct 2026 and are not real time.
Prism Medico and Pharmacy Ltd share price and key metrics
- Current price
- ₹30.5
- Market cap
- ₹41.4 cr
- Book value
- ₹21.7
- ROE
- 1.09%
- ROCE
- 1.65%
- Dividend yield
- 0.00%
- 52w high / low
- 34.5/15.5
Metrics as of 9 Oct 2026. Not real time.
Track Prism Medico and Pharmacy Ltd
Cruxal reads every Prism Medico and Pharmacy Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Prism Medico and Pharmacy Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -245%
- 10 Years
- 0%
- 5 Years
- 39%
- 3 Years
- 4%
- 1 Year
- 50%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 0%
- Last Year
- 1%
Prism Medico and Pharmacy Ltd quarterly results
In the quarter ended Dec 2019, sales were ₹9.75 cr, down 43.1% from ₹17.13 cr a year earlier. Net profit swung to a loss of ₹0.04 cr.
| ₹ crore | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.36 | 5.78 | 15 | 17.13 | 16.8 | 8.71 | 6.63 | 9.75 |
| Expenses | 0.54 | 5.35 | 14.68 | 16.89 | 17.39 | 8.54 | 6.39 | 9.75 |
| Operating profit | -0.25 | 0.42 | 0.29 | 0.21 | -0.63 | 0.17 | 0.17 | -0.07 |
| OPM % | -69.44% | 7.27% | 1.93% | 1.23% | -3.75% | 1.95% | 2.56% | -0.72% |
| Other income | 0.03 | 0.05 | 0.05 | -0 | 0.05 | -0 | -0 | 0.03 |
| Interest | 0.07 | 0.01 | 0.03 | 0.03 | 0.04 | -0 | 0.07 | 0.07 |
| Depreciation | 0.13 | 0.09 | 0.07 | 0.07 | 0.15 | 0.09 | 0.09 | -0 |
| Profit before tax | -0.35 | 0.38 | 0.27 | 0.14 | -0.73 | 0.08 | 0.08 | -0.04 |
| Tax % | 20.00% | -0.00% | -0.00% | -0.00% | -0.00% | -62.50% | -12.50% | -0.00% |
| Net profit | -0.42 | 0.37 | 0.28 | 0.15 | -0.73 | 0.13 | 0.09 | -0.04 |
| EPS (₹) | -0.69 | 0.61 | 0.46 | 0.25 | -1.20 | 0.21 | 0.15 | -0.07 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Prism Medico and Pharmacy Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | TTM |
|---|---|---|---|---|
| Sales | 5.27 | 22.78 | 54.43 | 41.89 |
| Operating profit | -0.08 | 0.54 | 0.22 | -0.36 |
| OPM % | -1.52% | 2.37% | 0.40% | -0.86% |
| Net profit | -0.22 | -0 | 0.04 | -0.55 |
| EPS (₹) | -0.36 | -0.00 | 0.07 | -0.91 |
TTM is the trailing twelve months to the most recent quarter.
Prism Medico and Pharmacy Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Sep 2019 |
|---|---|---|---|---|
| Equity capital | 6.06 | 6.06 | 6.06 | 6.06 |
| Reserves | 6.81 | 6.81 | 6.85 | 7.10 |
| Borrowings | 3.50 | 2.18 | 2.27 | -0.00 |
| Other liabilities | 0.89 | 0.75 | 6.03 | 11.73 |
| Total liabilities | 17.26 | 15.80 | 21.21 | 24.89 |
| Fixed assets | 9.91 | 9.31 | 8.91 | 8.94 |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | 2.61 | 1.36 | 1.36 |
| Other assets | 7.35 | 3.88 | 10.94 | 14.59 |
| Total assets | 17.26 | 15.80 | 21.21 | 24.89 |
As reported by the company. Total assets equal total liabilities by construction.
Prism Medico and Pharmacy Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| Cash from operations | -0.00 | 3.55 | -0.44 |
| Cash from investing | -0.00 | -2.53 | -0.00 |
| Cash from financing | -0.00 | -1.61 | -0.50 |
| Net cash flow | -0.00 | -0.59 | -0.95 |
| Free cash flow | -0.00 | 3.63 | -0.44 |
| CFO / operating profit | -0% | 430% | -121% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Prism Medico and Pharmacy Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 |
|---|---|---|---|
| ROE % | -1.71% | -0.16% | 1.09% |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Prism Medico and Pharmacy Ltd shareholding pattern
Promoters held 29.98% at Jun 2026, up from 25.00% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.50% | 29.98% |
| Public | 74.99% | 75.00% | 74.99% | 75.00% | 75.00% | 75.01% | 74.51% | 70.02% |
| No. of shareholders | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 | 4,295 | 4,177 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Prism Medico and Pharmacy Ltd corporate filings
- Prism Medico and Pharmacy Ltd files quarterly compliance intimation for September 2026Otherslow impact
Cruxal's analysis: The company, with a market cap of approximately 39.3 crore, has submitted a regulatory…
Read the full analysis - Dear Sir/ Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations, 2015 (LODR), please find the ....Otherslow impact
- Dear Sir/Madam, Pursuant to Code of Conduct to regulate, Monitor and report Trading by Insiders (''Code'') and applicable SEBI Regulations, please find the attached intimation by the ....Insider Trading / SASTlow impact
- Prism Medico and Pharmacy Limited secures shareholder approval for strategic investment in Infuze Well Private LimitedAGM/EGMmedium impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has successfully concluded its 24th Annual General…
Read the full analysis - Prism Medico and Pharmacy Ltd concludes 24th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd held its 24th Annual General Meeting on September 19, 2026…
Read the full analysis - Prism Medico and Pharmacy Limited Announces Outcome of 24th Annual General Meeting Including Strategic Investment ApprovalAGM/EGMlow impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has concluded its 24th Annual General Meeting, where…
Read the full analysis - Prism Medico and Pharmacy Ltd files Annual Report for FY 2025-2026Otherslow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has submitted its Annual Report for the financial year…
Read the full analysis - Prism Medico and Pharmacy Ltd announces record date for 24th Annual General MeetingCorp. Actionlow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has issued an intimation regarding the record date for its…
Read the full analysis - Prism Medico and Pharmacy Ltd announces book closure for 24th Annual General MeetingCorp. Actionlow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has issued an intimation regarding the book closure for its…
Read the full analysis - Prism Medico and Pharmacy Ltd files Annual Report for FY 2025-2026Company Updatelow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has submitted its Annual Report for the financial year…
Read the full analysis - Prism Medico and Pharmacy Ltd files Annual Report for FY 2025-2026Company Updatelow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has submitted its Annual Report for the financial year…
Read the full analysis - Prism Medico and Pharmacy Limited to Pivot Strategy via Strategic Investment in Infuze Well Private LimitedAGM/EGMhigh impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has announced a major shift in its capital allocation…
Read the full analysis - Prism Medico and Pharmacy Limited Announces 24th AGM and Strategic Re-allocation of Preferential Issue ProceedsBoard Meetingmedium impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has scheduled its 24th Annual General Meeting for…
Read the full analysis - Prism Medico and Pharmacy Limited schedules Board Meeting for August 24, 2026, to approve FY2026 financials and AGM agendaBoard Meetinglow impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has issued a formal intimation regarding a Board…
Read the full analysis - Prism Medico and Pharmacy Limited reports net loss of 5.83 lakh for Q1 FY2027 with zero revenue from operationsBoard Meetingmedium impact
Cruxal's analysis: Prism Medico and Pharmacy Limited reported a net loss of 5.83 lakh for the quarter ended…
Read the full analysis - Prism Medico and Pharmacy Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has formally intimated the stock exchanges regarding a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.